<?xml version="1.0" encoding="UTF-8"?>
<p>The inhibitory effects of medicinal plants extracts on the replication of several viruses were reported in the past six decades. In 1952, 288 plants for anti-influenza activity were evaluated by the Boots drug company (Nottingham, England); 12 out of these plants were found to be effective against influenza viruses in embryonated eggs (Chantrill et al. 
 <xref ref-type="bibr" rid="CR23_3">1952</xref>). In the 1970s, the antiviral activities of extracts from grape, apple, strawberry and other fruit juices against HSV, poliovirus type 1, coxsackievirus B5 and echovirus 7 were reported (Konowalchuk and Speirs 
 <xref ref-type="bibr" rid="CR86_3">1976</xref>, 
 <xref ref-type="bibr" rid="CR87_3">1978a</xref>, 
 <xref ref-type="bibr" rid="CR88_3">b</xref>). In 1995, 100 British Colombian medicinal plants were also reported to have antiviral activities, 12 out of which showed significant antiviral effect against corona viruses, respiratory syncytial virus (RSV), para-influenza virus type 3 (PI3), herpesvirus type 1 (HSV-1) and retavirus (McCutcheon et al. 
 <xref ref-type="bibr" rid="CR122_3">1995</xref>). In 1998, more than 800 common Chinese herbal medicines were detected for antiviral activities against HIV and more than 100 plants exhibited anti-HIV activities (Lou 
 <xref ref-type="bibr" rid="CR115_3">1998</xref>). In 2005, more than 200 Chinese herbal medicines were screened for antiviral activities against Severe Acute Respiratory Syndrome associated coronavirus (SARS-CoV), 4 out of which showed potent antiviral activities (Li et al. 
 <xref ref-type="bibr" rid="CR104_3">2005a</xref>).
</p>
